MétaCan
← tous les travaux

Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline

2018· article· en· 197 citations· W2889865404 sur OpenAlex· 10.1200/jco.18.00606

Pourquoi ce travail est-il dans la base ?

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

Affiliation canadienneUne personne signataire a déclaré un établissement canadien. C'est la seule voie dont dispose la base habituelle.

Le tri à trois modèles

les 1 000 travaux triés →

Les trois modèles l'ont jugé hors champ.

strate : aff_core · poids de sondage : 5595.24 (l'échantillon est stratifié ; tout taux calculé sans le poids est faux)
Claude Opus 4.8OUT
genre : policy
porte sur le Canada: non
confiance: high

ASCO endorsement of a clinical practice guideline for localized prostate cancer; a position document about clinical care, not about research practice.

GPT-5.6 (high)OUT
genre : policy
porte sur le Canada: non
confiance: high

The article endorses a prostate cancer clinical guideline and does not study research itself.

Grok 4.5OUT
genre : policy
porte sur le Canada: non
confiance: high

Clinical practice guideline endorsement for prostate cancer care, not study of research methods or systems.

Résumé

PURPOSE: In April 2017, the American Urological Association, American Society for Radiation Oncology, and Society of Urologic Oncology released a joint evidence-based practice guideline on clinically localized prostate cancer. The American Society of Clinical Oncology (ASCO) has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. METHODS: The Clinically Localized Prostate Cancer guideline was reviewed for developmental rigor by methodologists. An ASCO Expert Panel then reviewed the content and the recommendations. RESULTS: The ASCO Expert Panel determined that the recommendations from the Clinically Localized Prostate Cancer guideline were clear, thorough, and based upon the most relevant scientific evidence. ASCO endorsed the Clinically Localized Prostate Cancer guideline except for two recommendations on cryosurgery. The two recommendations covering cryosurgery were not endorsed because the panel found that there is insufficient evidence to support the use of cryotherapy in this setting. RECOMMENDATIONS: The ASCO Expert Panel endorsed all but two of the original guideline recommendations as written and offered a series of discussion points to guide practice.

Conservé avec la notice de tri, où il sert de preuve aux étiquettes ci-dessus.

La notice

Revue
Journal of Clinical Oncology
Thématique
Prostate Cancer Diagnosis and Treatment
Domaine
Medicine
Établissements canadiens
Princess Margaret Cancer Centre
Organismes subventionnaires
American Society of Clinical OncologyAmerican Society for Radiation Oncology
Mots-clés
GuidelineMedicineProstate cancerClinical OncologyOncologyFamily medicineRadiation oncologyInternal medicineCryotherapyProfessional associationCancerMedical physicsRadiation therapySurgeryPathology
Résumé présent dans OpenAlex
oui